Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs

Lignende værker

• Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
  af: Duintjer Tebbens, Radboud J., et al.
  Udgivet: (2015)
• Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
  af: Duintjer Tebbens, Radboud J., et al.
  Udgivet: (2017)
• Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers
  af: Duintjer Tebbens, Radboud J., et al.
  Udgivet: (2017)
• The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
  af: Thompson, Kimberly M., et al.
  Udgivet: (2015)
• Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy
  af: DUINTJER TEBBENS, R. J., et al.
  Udgivet: (2017)